Related references
Note: Only part of the references are listed.NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease
Dong-Hee Choi et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Vincent Braunersreuther et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Dynamic optical imaging of metabolic and NADPH oxidase-derived superoxide in live mouse brain using fluorescence lifetime unmixing
David J. Hall et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice
Kari A. Trumbull et al.
NEUROBIOLOGY OF DISEASE (2012)
The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials
Ettore Beghi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2011)
Significance of Marrow-Derived Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Ischemic Stroke
Xian N. Tang et al.
ANNALS OF NEUROLOGY (2011)
Antioxidant Therapeutics for Schizophrenia
Ravinder Reddy et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Radical changes in multiple sclerosis pathogenesis
Jack van Horssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors
Francesca Gaggini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats
Tiziana Genovese et al.
BRAIN RESEARCH (2011)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action
Vincent Jaquet et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Radhamani Kannaiyan et al.
CANCER LETTERS (2011)
The Seeds of Neurodegeneration: Prion-like Spreading in ALS
Magdalini Polymenidou et al.
CELL (2011)
Oral Therapies for Multiple Sclerosis A Review of Agents in Phase III Development or Recently Approved
Ralf Gold
CNS DRUGS (2011)
Amyotrophic Lateral Sclerosis Pathophysiology, Diagnosis and Management
Paul H. Gordon
CNS DRUGS (2011)
Alzheimer's Disease: Emerging Trends in Small Molecule Therapies
T. Mohamed et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Inflammatory Demyelinating Neuropathies
Glenn Lopate et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options
Peter Wipfler et al.
DRUG DISCOVERY TODAY (2011)
Foundation review: Phenothiazine: the seven lives of pharmacology's first lead structure
Maike J. Ohlow et al.
DRUG DISCOVERY TODAY (2011)
NADPH-oxidase activation and cognition in Alzheimer disease progression
Mubeen A. Ansari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
The role of free radical generation in increasing cerebrovascular permeability
Paul A. Fraser
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis
Francisco Javier Miana-Mena et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2011)
NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia
Hideyuki Yoshioka et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR
Ana M. Briones et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
NADPH oxidase-mediated oxidative damage to proteins in the postsynaptic density after transient cerebral ischemia and reperfusion
Kazutoshi Murotomi et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Glia: Initiators and Progressors of Pathology in Parkinson's Disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2011)
Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease
Magali Dumont et al.
NEUROSCIENCE LETTERS (2011)
Intermittent Hypoxia-Induced Cognitive Deficits Are Mediated by NADPH Oxidase Activity in a Murine Model of Sleep Apnea
Deepti Nair et al.
PLOS ONE (2011)
Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)SL Mice
Melinda E. Lull et al.
PLOS ONE (2011)
Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3
Phillip M. Rappold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer Cells
Davide Gianni et al.
ACS CHEMICAL BIOLOGY (2010)
Alcohol-Induced Exacerbation of Ischemic Brain Injury: Role of NAD(P)H Oxidase
Honggang Zhao et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
The neurobiology of isoprostanes and Alzheimer's disease
Domenico Pratico
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity
Shannon Levesque et al.
BRAIN (2010)
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
S. Wind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Severe Depression, Suicide Attempts, and Ideation During the Use of Interferon Beta by Patients With Multiple Sclerosis
Yara Dadalti Fragoso et al.
CLINICAL NEUROPHARMACOLOGY (2010)
The Development of New Therapeutics for Alzheimer's Disease
M. D. Carter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease
Santiago Perez-Lloret et al.
CNS DRUGS (2010)
Cognitive decline following major surgery is associated with gliosis, β-amyloid accumulation, and τ phosphorylation in old mice
Yanjie Wan et al.
CRITICAL CARE MEDICINE (2010)
Glatiramer Acetate A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
Natalie J. Carter et al.
DRUGS (2010)
Multiple non-psychiatric effects of phenothiazines: A review
Gangopadhyay Sudeshna et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Dual oxidase, hydrogen peroxide and thyroid diseases
Hidemi Ohye et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Treating multiple sclerosis with fingolimod or intramuscular interferon
Carlo Pozzilli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target
Dong Kug Choi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Antioxidant approaches for the treatment of Alzheimer's disease
Hyun Pil Lee et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
Raymond C. S. Seet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Sian C. Barber et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration
David A. Patten et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
NADPH Oxidases Regulate CD44 and Hyaluronic Acid Expression in Thrombin-treated Vascular Smooth Muscle Cells and in Atherosclerosis
Aleksandr E. Vendrov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barre syndrome
Natalia Mossberg et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
Natalizumab Therapy of Multiple Sclerosis
Michael Hutchinson
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Critical Review: Assessment of Interferon-beta Immunogenicity in Multiple Sclerosis
Klaus Bendtzen
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
Benoit Laleu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Small-Molecule Inhibitors of NADPH Oxidase 4
Gabor Borbely et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
Daniel Paris et al.
JOURNAL OF NEUROINFLAMMATION (2010)
The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses
Silvia Sorce et al.
JOURNAL OF NEUROSCIENCE (2010)
Stroke Prevention and Treatment
James D. Marsh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Targeting NADPH Oxidase and Phospholipases A(2) in Alzheimer's Disease
Agnes Simonyi et al.
MOLECULAR NEUROBIOLOGY (2010)
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
John M. Lincecum et al.
NATURE GENETICS (2010)
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
James J. Marriott et al.
NEUROLOGY (2010)
Reactive oxygen species generated by NADPH oxidase are involved in neurodegeneration in the pilocarpine model of temporal lobe epilepsy
Rafaela R. F. Pestana et al.
NEUROSCIENCE LETTERS (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease
Cynthia A. Massaad et al.
PLOS ONE (2010)
Reactive oxygen species and the brain in sleep apnea
Yang Wang et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2010)
Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia
Liu Hui-guo et al.
SLEEP MEDICINE (2010)
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy
M. Sedeek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Nox5 and the Regulation of Cellular Function
David J. R. Fulton
ANTIOXIDANTS & REDOX SIGNALING (2009)
NOX Enzymes in the Central Nervous System: From Signaling to Disease
Silvia Sorce et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
The Role of NADPH Oxidase 1-Derived Reactive Oxygen Species in Paraquat-Mediated Dopaminergic Cell Death
Ana Clara Cristovao et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Targeting and Regulation of Reactive Oxygen Species Generation by Nox Family NADPH Oxidases
Thomas L. Leto et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Vincent Jaquet et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats
Stefania Schiavone et al.
BIOLOGICAL PSYCHIATRY (2009)
NOX2 inhibition with apocynin worsens stroke outcome in aged rats
Kimberly A. Kelly et al.
BRAIN RESEARCH (2009)
Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice
K. A. Jackman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Hereditary Deficiency of gp91phox Is Associated With Enhanced Arterial Dilatation Results of a Multicenter Study
Francesco Violi et al.
CIRCULATION (2009)
Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers
Daniela Giustarini et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Neurobiology of cognitive disorders
Alexander Kurz et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease
Gjumrakch Aliev et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion
Hai Chen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Advanced Intercross Line Mapping Suggests That Ncf1 (Ean6) Regulates Severity in an Animal Model of Guillain-Barre Syndrome
Alexander Huberle et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic mapping-the path of discovery for novel functions of the NOX NADPH oxidases
Vincent Jaquet et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Oxygen radical production in leukocytes and disease severity in multiple sclerosis
Natalia Mossberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Neuroprotection by the NR3A Subunit of the NMDA Receptor
Nobuki Nakanishi et al.
JOURNAL OF NEUROSCIENCE (2009)
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation
Angela M. Brennan et al.
NATURE NEUROSCIENCE (2009)
Mitoxantrone: benefits and risks in multiple sclerosis patients
V. Martinelli et al.
NEUROLOGICAL SCIENCES (2009)
Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?
M. Margarita Behrens et al.
NEUROPHARMACOLOGY (2009)
Stroke: roles of B vitamins, homocysteine and antioxidants
Concepcion Sanchez-Moreno et al.
NUTRITION RESEARCH REVIEWS (2009)
Oxidative-Nitrosative Stress in a Rabbit Pup Model of Germinal Matrix Hemorrhage Role of NAD(P)H Oxidase
Muhammad T. Zia et al.
STROKE (2009)
The protective role of ROS in autoimmune disease
Malin Hultqvist et al.
TRENDS IN IMMUNOLOGY (2009)
Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia
Roderic H. Fabian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Oxidative stress biomarkers in sporadic ALS
Hiroshi Mitsumoto et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Glucose and NADPH Oxidase Drive Neuronal Superoxide Formation in Stroke
Sang Won Suh et al.
ANNALS OF NEUROLOGY (2008)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Classical Inhibitors of NOX NAD(P) H Oxidases Are Not Specific
Elisabetta Aldieri et al.
CURRENT DRUG METABOLISM (2008)
Advancement of therapies for neuroprotection in multiple sclerosis
Albert Lo
Expert Review of Neurotherapeutics (2008)
Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant
Sabine Heumueller et al.
HYPERTENSION (2008)
New developments in understanding and treating neuroinflammation
C. Infante-Duarte et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke
Wenlan Liu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
M. Margarita Behrens et al.
JOURNAL OF NEUROSCIENCE (2008)
Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice
Anbrin Masood et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Apocynin: Molecular Aptitudes
J. Stefanska et al.
MEDIATORS OF INFLAMMATION (2008)
Apocynin improves outcome in experimental stroke with a narrow dose range
X. N. Tang et al.
NEUROSCIENCE (2008)
Bioavailability of apocynin through its conversion to glycoconjugate but not to diapocynin
Qun Wang et al.
PHYTOMEDICINE (2008)
Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
Laibaik Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NOX enzymes as novel targets for drug development
J. David Lambeth et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Excess Salt Causes Cerebral Neuronal Apoptosis and Inflammation in Stroke-Prone Hypertensive Rats Through Angiotensin II-Induced NADPH Oxidase Activation
Eiichiro Yamamoto et al.
STROKE (2008)
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Claire Henchcliffe et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase
M. Margarita Behrens et al.
SCIENCE (2007)
Oxygen radical production and severity of the Guillain-Barre syndrome
Natalia Mossberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke
Timo Kahles et al.
STROKE (2007)
Redox modifier genes in amyotrophic lateral sclerosis in mice
Jennifer J. Marden et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells
Harald H. Hofstetter et al.
CYTOKINE (2007)
Selective loss of catecholaminergic wake-active neurons in a murine sleep apnea model
Yan Zhu et al.
JOURNAL OF NEUROSCIENCE (2007)
Effects of apocynin and ethanol on intracerebral haemorrhage-induced brain injury in rats
Elena Titova et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Apocynin attenuates cerebral infarction after transient focal ischaemia in rats
L. L. Tang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2007)
Inhibition of NAD(P)H oxidase reduces fibronectin expression in stroke-prone renovascular hypertensive rat brain
Chunmei Cui et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase
Sang Won Suh et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
Maya G. Purisai et al.
NEUROBIOLOGY OF DISEASE (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Perhexiline
Houman Ashrafian et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
A key role for the microglial NADPH oxidase in APP-dependent killing of neurons
Bin Qin et al.
NEUROBIOLOGY OF AGING (2006)
A new arthritis therapy with oxidative burst inducers
Malin Hultqvist et al.
PLOS MEDICINE (2006)
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice
Du-Chu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 Deficiency
F. Violi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus
Qun Wang et al.
BRAIN RESEARCH (2006)
A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons
JW Kinney et al.
JOURNAL OF NEUROSCIENCE (2006)
NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea
GX Zhan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity
C Cleren et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process
K Benchenane et al.
STROKE (2005)
Cortical inhibitory neurons and schizophrenia
DA Lewis et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Mahmoud Kiaei et al.
NEURODEGENERATIVE DISEASES (2005)
Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission
A Leng et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia
LY Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene
M Hultqvist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Interferons in relapsing remitting multiple sclerosis: a systematic review
G Filippini et al.
LANCET (2003)
Positional identification of Ncf1 as a gene that regulates arthritis severity in rats
P Olofsson et al.
NATURE GENETICS (2003)
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients
GE Carpagnano et al.
CHEST (2002)
Oxidatively modified proteins in aging and disease
MF Beal
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits
DW Beebe et al.
JOURNAL OF SLEEP RESEARCH (2002)
Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics
EA Peters et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Neuroprotection for ischaemic stroke - An unattainable goal?
DS Liebeskind et al.
CNS DRUGS (2001)
Catching up on schizophrenia: Natural history and neurobiology
DA Lewis et al.
NEURON (2000)
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea - Impact of continuous positive airway pressure therapy
R Schulz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Activation of NADPH oxidase in Alzheimer's disease brains
S Shimohama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
